help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braddon, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braddon, S. A.

Endocrinology, Vol 102, 1292-1299, Copyright © 1978 by Endocrine Society

ARTICLES

Relaxin-dependent adenosine 6',5'-monophosphate concentration changes in the mouse pubic symphysis

SA Braddon

The amount of cAMP in the pubic symphyses of estrogen-primed mice increases after injection of the hormone relaxin. This relaxin-induced increase in symphyseal cAMP was observed in immature, mature, and ovariectomized mature mice and could be prevented by prior ip injection of rabbit antibodies to porcine relaxin or by treatment of relaxin with dithiothreitol. The highest level of cAMP was measured 30 min after relaxin injection; the level of measurable cMAP then diminished rapidly. Estrogen-priming of the mice was not a prerequisite for a relaxin-induced response to occur. Relaxin administration did not increase the level of cAMP in a non-target tissue such as liver, nor could an increase in cAMP in the pubic symphysis be elicited by injection of insulin, a protein of similar size and structure, or glucagon, a known stimulator of liver cAMP levels.


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
M. L. Halls, R. A. D. Bathgate, and R. J. Summers
Relaxin Family Peptide Receptors RXFP1 and RXFP2 Modulate cAMP Signaling by Distinct Mechanisms
Mol. Pharmacol., July 1, 2006; 70(1): 214 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers
International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides.
Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. T. Nguyen and C. W. Dessauer
Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production
Mol. Endocrinol., April 1, 2005; 19(4): 1012 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Palejwala, D. E. Stein, G. Weiss, B. P. Monia, D. Tortoriello, and L. T. Goldsmith
Relaxin Positively Regulates Matrix Metalloproteinase Expression in Human Lower Uterine Segment Fibroblasts Using a Tyrosine Kinase Signaling Pathway
Endocrinology, August 1, 2001; 142(8): 3405 - 3413.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Palejwala, D. Stein, A. Wojtczuk, G. Weiss, and L. T. Goldsmith
Demonstration of a Relaxin Receptor and Relaxin-Stimulated Tyrosine Phosphorylation in Human Lower Uterine Segment Fibroblasts
Endocrinology, March 1, 1998; 139(3): 1208 - 1212.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1978 by The Endocrine Society